Доказательный подход к лечению острого синусита

Обложка

Цитировать

Полный текст

Аннотация

Воспалительные заболевания околоносовых пазух - наиболее распространенные патологии ЛОР-органов во всех возрастных группах. Среди больных, находящихся на лечении в оториноларингологических стационарах, от 15 до 36% составляют пациенты, страдающие заболеваниями околоносовых пазух. В амбулаторной практике доля пациентов с синуситами приблизительно такая же. Острый синусит является одним из наиболее распространенных заболеваний, с которыми сталкиваются врачи первичной медико-санитарной помощи.

Об авторах

Андрей Борисович Туровский

ГБУЗ «Научно-исследовательский клинический институт оториноларингологии им. Л.И.Свержевского» Департамента здравоохранения г. Москвы

Email: an_tur@mail.ru
д-р мед. наук, проф., зам. директора по медицинской части 17152, Россия, Москва, Загородное ш., д. 18а, стр. 2

Инна Григорьевна Колбанова

ГБУЗ «Научно-исследовательский клинический институт оториноларингологии им. Л.И.Свержевского» Департамента здравоохранения г. Москвы

канд. мед. наук, ст. науч. сотр. отд. патологии верхних дыхательных путей и ринофациальной эстетической хирургии 17152, Россия, Москва, Загородное ш., д. 18а, стр. 2

Юлианна Сергеевна Кудрявцева

ГБУЗ «Научно-исследовательский клинический институт оториноларингологии им. Л.И.Свержевского» Департамента здравоохранения г. Москвы

канд. мед. наук, ст. науч. сотр. отд. патологии верхних дыхательных путей и ринофациальной эстетической хирургии, зав. отд-нием по оказанию платных медицинских услуг 17152, Россия, Москва, Загородное ш., д. 18а, стр. 2

Список литературы

  1. Gonzales R, Steiner J.F, Lum A, Barrett P.H.Jr. Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA 1999; 281: 1512-9.
  2. Sharp H.J, Denman D, Puumala S, Leopold D.A. Treatment of acute and chronic rhinosinusitis in the United States, 1999-2002. Arch Otolaryngol Head Neck Surg 2007; 133: 260-5.
  3. Fairlie T, Shapiro D.J, Hersh A.L, Hicks L.A. National trends in visit rates and antibiotic prescribing for adults with acute sinusitis. Arch Intern Med 2012; 172: 1513-4.
  4. Smith S.S, Kern R.C, Chandra R.K. et al. Variations in antibiotic prescribing of acute rhinosi-nusitis in United States ambulatory settings. Otolaryngol Head Neck Surg 2013; 148: 852-9.
  5. Garbutt J.M., Banister C, Spitznagel E, Piccirillo J.F. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA 2012; 307: 685-92.
  6. Ahovuo-Saloranta A, Borisenko O.V., Kovanen N. et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008: CD000243.
  7. Fokkens W.J., Lund V.J., Mullol J. et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology 2012; 50: 1-307.
  8. Smith S.R, Montgomery L.G, Williams J.W.Jr. Treatment of mild to moderate sinusitis. Arch Intern Med 2012; 172: 510-3.
  9. Rosenfeld R.M, Andes D, Bhattacharyya N et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg 2007; 137: S1-31.
  10. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007; p. 1-136.
  11. Meltzer E.O., Hamilos D.L. Rhinosinusitis diagnosis and management for the clinician: a synopsis of recent consensus guidelines. Mayo Clin Proc 2011; 86: 427-443.
  12. Острый синусит. Клинические рекомендации. М., 2016.
  13. Young Kyung Yoon, Chan-Soon Park, Jae Wook Kim et al. Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections. Infect Chemother 2017; 49 (4): 326-52.
  14. Meltzer E.O, Hamilos D.L, Hadley J.A. et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114: 155-212.
  15. Anon J.B, Jacobs M.R, Poole M.D. et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004; 130: 1-45.
  16. Rosenfeld R.M. Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg 2007;137:365-77.
  17. Anzai Y, Jarvik J.G, Sullivan S.D, Hollingworth W. The cost-effectiveness of the management of acute sinusitis. Am J Rhinol 2007; 21: 444-51.
  18. Balk E.M, Zucker D.R, Engels E.A. et al. Strategies for diagnosing and treating suspected acute bacterial sinusitis: a cost-effectiveness analysis. J Gen Intern Med 2001; 16: 701-11.
  19. Amin N.M, Breadon G. An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis. Clin Ther 1995; 17: 701-7.
  20. Anon J.B, Ferguson B, Twynholm M et al. Pharmacokinetically enhanced amoxicillin/clavu-lanate (2,000/125 mg) in acute bacterial rhinosinusitis caused by Streptococcus pneumoniae, including penicillin-resistant strains. Ear Nose Throat J 2006; 85: 500, 502, 504.
  21. Arrieta J.R, Galgano A.S, Sakano E et al. Moxifloxacin vs amoxicillin/clavulanate in the treatment of acute sinusitis. Am J Otolaryngol 2007; 28: 78-82.
  22. Benninger M.S, Payne S.C, Ferguson B.J. et al. Endoscopically directed middle meatal cultures versus maxillary sinus taps in acute bacterial maxillary rhinosinusitis: a meta-analy-sis. Otolaryngol Head Neck Surg 2006; 134: 3-9.
  23. Shintani S Smith, Henderson E Ference et al. The prevalence of bacterial infection in acute rhinosinusitis: A systematic review and meta-analysis. Laryngoscope 2015; 125 (1): 57-69.
  24. Slavin R.G, Spector S.L, Bernstein I.L. et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005; 116: S13-47.
  25. American Academy of Allergy A & Immunology. Choosing Wisely: Five Things Physicians and Patients Should Question. 2012.
  26. Meltzer E.O, Hamilos D.L, Hadley J.A. et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114: 155-212.
  27. Chow A.W., Benninger M.S., Brook I et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis in Children and Adults. Clin Infect Dis 2012; 54: e72-e112.
  28. Fokkens W.J., Lund V.J, Mullol J et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinol Suppl 2012; 50: 1-12.
  29. Chow A.W., Benninger M.S., Brook I et al. Infectious Diseases Society of America IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis 2012; 54: e72-e112.
  30. Rosenfeld R.M, Piccirillo J.F, Chandrasekhar S.S et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg 2015; 152 (Suppl.): S1-S39.
  31. Gwaltney J.M.Jr, Scheld W.M, Sande M.A, Sydnor A. The microbial etiology and antimicrobial therapy of adults with acute community-acquired sinusitis: a fifteen-year experience at the University of Virginia and review of other selected studies. J Allergy Clin Immunol. 1992; 90: 457-61.
  32. Sokol W. Epidemiology of sinusitis in the primary care setting: results from the 1999-2000 respiratory surveillance program. Am J Med 2001; 111 (Suppl. 9A): 19S-24S.
  33. Ahovuo-Saloranta A, Rautakorpi U.M, Borisenko O.V. et al. Antibiotics for acute maxillary sinusitis in adults. Cochrane Database Syst Rev 2014: CD000243.
  34. Henry D.C., Riffer E, Sokol W.N. et al. Randomized double-blind study comparing 3-and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. Antimicrob Agents Chemother. 2003; 47: 2770-4.
  35. Luterman M, Tellier G, Lasko B, Leroy B. Efficacy and tolerability of telithromycin for 5 or 10 days vs amoxicillin/clavulanic acid for 10 days in acute maxillary sinusitis. Ear Nose Throat J 2003; 82: 576-80, 582-4.
  36. Berg O, Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol 1988; 105: 343-9.
  37. Jenkins S.G., Farrell D.J., Patel M, Lavin B.S. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J Infect 2005; 51: 355-63.
  38. Falagas M.E., Karageorgopoulos D.E., Grammatikos A.P., Matthaiou D.K. Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta-analysis of randomized trials. Br J Clin Pharmacol 2009; 67: 161-71.
  39. Lemiengre M.B, van Driel M.L, Merenstein D et al. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev 2012; 10: CD006089.
  40. Jacobs M.R. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Expert Rev Anti Infect Ther 2008; 6: 619-35.
  41. Lynch J.P. 3rd, Zhanel G.G. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines. Curr Opin Pulm Med 2010; 16: 217-25.
  42. Karageorgopoulos D.E., Giannopoulou K.P., Grammatikos A.P. et al. Fluoroquinolones compared with betalactam antibiotics for the treatment of acute bacterial sinusitis: a metaanalysis of randomized controlled trials. CMAJ 2008; 178: 845-54.
  43. Harrison C.J., Woods C, Stout G et al. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother 2009; 63: 511-9.
  44. Desrosiers M, Evans G.A., Keith P.K. et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. J Otolaryngol Head Neck Surg 2011; 40 (Suppl. 2): S99-S193.
  45. Fenoll A, Gim6nez M.J., Robledo O et al. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin. J Chemother 2008; 20: 175-9.
  46. Fenoll A, Gim6nez M.J, Robledo O et al. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 2008; 27: 75-80.
  47. Sader H.S, Jacobs M.R, Fritsche T.R. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate. Diagn Microbiol Infect Dis 2007; 57 (Suppl): 5S-12S.
  48. Jansen W.T, Verel A, Beitsma M et al. Surveillance study of the susceptibility of Haemophi-lus influenzae to various antibacterial agents in Europe and Canada. Curr Med Res Opin 2008; 24: 2853-61.
  49. Fenoll A, Aguilar L, Robledo O et al. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J Antimicrob Chemother 2007;60:323-7.
  50. Poachanukoon O, Kitcharoensakkul M. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial. Clin Ther 2008; 30: 1870-9.
  51. Ebell M.H., Smith M.A., Barry H.C. et al. Does this patient have strep throat? JAMA 2000; 284: 2912-8.
  52. Gidengil C.A., Kruskal B.A., Lee G.M. Initial antibiotic choice in the treatment of group A streptococcal pharyngitis and return visit rates. J Pediatric Infect Dis Soc 2013; 2: 361-7.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО "Консилиум Медикум", 2018

Creative Commons License
Эта статья доступна по лицензии Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).